Karin Ilg

Introduction: Karin Ilg is an accomplished inventor based in Zurich, Switzerland. With two patents to her name, she has made significant contributions to the fields of medical and pharmaceutical sciences. Her work reflects her dedication to advancing innovation through rigorous research.

Latest Patents: Karin Ilg's recent patents encompass groundbreaking research involving the pgl operon and its derivatives. Her latest inventions relate to the presentation of N-glycans on cell surfaces, focusing on medical applications to treat and prevent infections. These patents not only highlight her expertise in biomedicine but also underscore her commitment to developing effective pharmaceutical compositions.

Career Highlights: Karin is associated with the prestigious Eidgenössische Technische Hochschule Zurich, a leading institution renowned for its engineering and technology programs. Her role there allows her to engage deeply with scientific inquiry and innovation, solidifying her status as a key figure in her field.

Collaborations: Throughout her career, Karin Ilg has worked alongside distinguished colleagues like Markus Aebi and Umesh Ahuja. These collaborations have been instrumental in driving forward her research initiatives and enhancing the overall impact of her work.

Conclusion: Karin Ilg stands out as a notable inventor in Zurich, armed with significant patents that reflect her innovative spirit. Her ongoing research and collaborations continue to contribute to the development of novel medical solutions, reinforcing her reputation as a pioneer in her field.

Profile summary based on public USPTO records.